Category Archives: healthcare

Celgene’s Abraxane to Lead Boom in Pancreatic Cancer Market

The global pancreatic cancer treatment market value in the six major countries (U.S., France, Germany, Italy, Spain and the UK) will increase  from $529 million in 2012 to $1.63 billion by 2017, at a Compound Annual Growth Rate (CAGR) of 25.2%, says a new report from GlobalData (London, UK). According to the report, the U.S. will […]
Also posted in Gene therapy, Global | Tagged , , , | Leave a comment

The Rise of the Patient Participant

Either the doctor’s best friend or nightmare, the e-patient movement (the ‘e’ could stand for engaged or empowered) is here to stay and growing, writes Marylyn Donahue. Championing patients as full partners in their own medical care, via the use of online communities and social media sites are slowly but surely turning patients into participants […]
Also posted in E-Media, Medical Education, multimedia, Patient Communication, patient education, social media, Technology | Tagged , , , | Leave a comment

UK Drug Pricing: An ICER of Zero?

by Leela Barham The incremental cost effectiveness ratio (ICER) – or the threshold for determining whether the costs of a new medicine are worth it – has been controversial since it’s inception. There are those who deny that anyone can put a price-tag on life; those that accept the concept but are happy to let […]
Also posted in Europe, Guest Blog, Legal, Market Access, pricing, Regulatory, Strategy | Tagged , , , , , | Leave a comment

Casing Cancer: ASCO Launches New Series on State of the Disease

Despite its importance as a vital indicator of overall population health status, cancer suffers from an information deficit – particularly when considered from a global perspective. The American Society of Clinical Oncology [ASCO], the lead professional group in this space, is now working to rectify at least part of the gap with the launch of […]
Also posted in leadership, Market Access, pricing, R&D, Regulatory, Safety, Strategy | Tagged , , , , , | Leave a comment

FDA Details National Vaccine Plan

Dr. Karen Midthun, director of FDA’s Center for Biologics Evaluation and Research, outlined the importance of the Department of Health and Human Services (HHS) National Vaccine Plan, in a FDA blog on March 11, 2014. Midthun points out how crucial vaccines are in protecting public health and discusses FDA’s role in ensuring a stable supply […]
Also posted in FDA, Regulatory | Tagged , , | Leave a comment
  • Categories

  • Meta